← 產業報告目錄
Regenerative Medicine Market Size, Share & Trends Analysis Report By Product (Therapeutics, Primary cell-based therapeutics, Stem Cell & Progenitor Cell-based therapeutics), By Therapeutic Category (Dermatology, Musculoskeletal, Immunology & Inflammation, and Oncology), By Region, And Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-01-17頁數 180報告編號 INSIGHTACE-5bfc128b3e
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The Regenerative Medicine Market is positioned for steady expansion, with a projected CAGR of 15.2% from 2025 to 2034.
Regenerative Medicine encompasses The preference for individualized therapeutic approaches over conventional treatment modalities has changed due to several developments in biological therapy. The sector has gained traction as organizations seek innovative approaches to address evolving healthcare challenges.
Several factors contribute to this trajectory, including heightened requirement next-generation products, expanding applications across diverse end-use sectors, and supportive government initiatives.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region expected to deliver the strongest growth trajectory through the forecast period, bolstered by demographic shifts and policy support.
Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Regenerative Medicine Market Snapshot
Chapter 4. Global Regenerative Medicine Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Product Type Estimates & Trend Analysis
5.1. by Product Type & Market Share, 2024 & 2034
5.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Product Type:
5.2.1. Therapeutics
5.2.1.1. Primary cell-based therapeutics
5.2.1.1.1. Dermatology
5.2.1.1.2. Musculoskeletal
5.2.1.1.3. Surgical
5.2.1.1.4. Dental
5.2.1.1.5. Others
5.2.1.2. Stem Cell & Progenitor Cell-based therapeutics
5.2.1.2.1. Autologous
5.2.1.2.2. Allogenic
5.2.1.2.3. Others
5.2.1.3. Cell-based Immunotherapies
5.2.1.4. Gene Therapies
5.2.2. Tools
5.2.3. Banks
5.2.4. Services
Chapter 6. Market Segmentation 2: by Therapeutic Estimates & Trend Analysis
6.1. by Therapeutic & Market Share, 2024 & 2034
6.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Therapeutic:
6.2.1. Dermatology
6.2.2. Musculoskeletal
6.2.3. Immunology & Inflammation
6.2.4. Oncology
6.2.5. Cardiovascular
6.2.6. Ophthalmology
6.2.7. Others
Chapter 7. Regenerative Medicine Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America Regenerative Medicine Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034
7.1.2. North America Regenerative Medicine Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic, 2021-2034
7.1.3. North America Regenerative Medicine Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
7.2. Europe
7.2.1. Europe Regenerative Medicine Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034
7.2.2. Europe Regenerative Medicine Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic, 2021-2034
7.2.3. Europe Regenerative Medicine Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
7.3. Asia Pacific
7.3.1. Asia Pacific Regenerative Medicine Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034
7.3.2. Asia Pacific Regenerative Medicine Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic, 2021-2034
7.3.3. Asia Pacific Regenerative Medicine Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
7.4. Latin America
7.4.1. Latin America Regenerative Medicine Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034
7.4.2. Latin America Regenerative Medicine Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic, 2021-2034
7.4.3. Latin America Regenerative Medicine Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
7.5. Middle East & Africa
7.5.1. Middle East & Africa Regenerative Medicine Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034
7.5.2. Middle East & Africa Regenerative Medicine Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic, 2021-2034
7.5.3. Middle East & Africa Regenerative Medicine Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. AstraZeneca plc
8.2.2. F. Hoffmann-La Roche Ltd.
8.2.3. Integra Lifesciences Corp.
8.2.4. Astellas Pharma, Inc.
8.2.5. Cook Biotech, Inc.
8.2.6. Bayer AG
8.2.7. Pfizer, Inc.
8.2.8. Merck KGaA
8.2.9. Abbott
8.2.10. Vericel Corp.
8.2.11. Novartis AG
8.2.12. GlaxoSmithKline (GSK)
8.2.13. Baxter International, Inc.
8.2.14. Boehringer Ingelheim
8.2.15. Amgen Inc.
8.2.16. Cesca Therapeutics, Inc.
8.2.17. U.S. Stem Cell, Inc.
8.2.18. Bristol-Myers Squibb
8.2.19. Eli Lilly and Company
8.2.20. NuVasive, Inc.
8.2.21. Organogenesis, Inc.
8.2.22. MiMedx Group, Inc.
8.2.23. Takara Bio, Inc.
8.2.24. Osiris Therapeutics, Inc.
8.2.25. Corline Biomedical AB
8.2.26. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們